Belgium

Marketing authorisation holders of a medicinal product for human use are required to follow certain guidelines for the labelling and packaging of medicinal products. These guidelines (“Labelling of medicinal products” ) have recently been updated.

The main changes are a clarification in the sections “Readability” and “Sufficient distinction” of the mock-ups in order to avoid medication errors. The guidelines have now been brought into line with the European directives and other national or international agreements.

Source: https://www.fagg-afmps.be/nl/news/bijgewerkte_richtlijnen_voor_de_etikettering_en_verpakking_van_geneesmiddelen_voor_menselijk

Share This